Manuel D. Delgado
Santander, CB 39011, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
CTCF Regulates Erythroid Differentiation Through Control of Core Erythroid Transcription Factors.
Journal: Biomolecules
Published: February 23, 2026
MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells.
Journal: Oncogene
Published: February 01, 2023
Correction: A novel role of MNT as a negative regulator of REL and the NF-κB pathway.
Journal: Oncogenesis
Published: August 03, 2021
A novel role of MNT as a negative regulator of REL and the NF-κB pathway.
Journal: Oncogenesis
Published: April 10, 2020
The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.
Journal: The Journal of biological chemistry
Published: July 28, 2019
Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells.
Journal: Scientific reports
Published: January 10, 2019
The epigenetic regulator CTCF modulates BCL6 in lymphoma.
Journal: Oncoscience
Published: September 07, 2015
In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone.
Journal: Leukemia
Published: June 11, 2014
Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication.
Journal: Haematologica
Published: October 27, 2012
MYC oncogene in myeloid neoplasias.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 06, 2012
Last Updated: 09/26/2026